miR-17~92 microRNA家族在胸腺T细胞发育和T淋巴细胞白血病中的作用及致病机理研究

基本信息
批准号:31770953
项目类别:面上项目
资助金额:65.00
负责人:肖昌春
学科分类:
依托单位:厦门大学
批准年份:2017
结题年份:2021
起止时间:2018-01-01 - 2021-12-31
项目状态: 已结题
项目参与者:杜治强,范文竹,杨超,杨康,廖堃玉,李琼
关键词:
胸腺β选择淋巴细胞T淋巴细胞白血病胸腺microRNA
结项摘要

T cell development in the thymus is controlled by a multistep differentiation program under stringent quality control at multiple checkpoints. Dysregulation of molecular pathways controlling thymocyte development can cause immunodeficiency, thymocyte malignant transformation, and development of T cell acute lymphoblastic leukemia (T-ALL). Our understanding of the molecular events controlling T cell development and leukemogenesis remains limited. MicroRNAs (miRNAs) have recently emerged as major trans-factors that regulate the expression of protein coding genes. They control many diverse biological processes including cell differentiation, proliferation, and apoptosis. Hundreds of miRNAs are expressed in thymocytes, but it is unclear which ones are important for T cell development and malignant transformation. The miR-17~92 family comprises three miRNA clusters that encode 13 distinct miRNAs. Our preliminary studies show that miR-17~92 family miRNAs are highly expressed in thymocytes and T-ALL leukemia cells, that their LckCre-mediated conditional co-deletion in thymocytes caused a severe block of β-selection with a 10-fold reduction in CD4+CD8+ double positive (DP) thymocyte numbers, and that transgenic expression of miR-17~92 in mature T cells led to spontaneous T cell activation, proliferation, and fatal immunopathology. In this proposal, we will further investigate how miR-17~92 family miRNAs control T cell development and leukemogenesis, and elucidate the underlying molecular mechanisms. Upon the completion of this project, we expect to identify key miR-17~92 miRNAs and their downstream targets as novel therapeutic modalities or targets for the development of therapeutic interventions for the purpose of treating immunodeficiency and T-ALLs.

胸腺T细胞发育受阻或失控能够诱发严重的免疫缺陷或T淋巴细胞白血病(T-ALL)等疾病。厘清胸腺T细胞发育的调控机制对于揭示上述疾病的致病机理至关重要。miRNA在外周T细胞的功能逐渐被揭示,但在胸腺T细胞发育中的作用机制仍不清楚。本课题前期研究发现miR-17~92家族在胸腺T细胞和T-ALL的T细胞中均高丰度表达;miR-17~92家族缺失在小鼠中导致胸腺T细胞发育严重受阻,外周T细胞数量锐减;而T细胞特异性过表达miR-17~92转基因小鼠中T细胞会过度增殖活化。提示miR-17~92家族在胸腺T细胞发育和T-ALL中发挥关键作用。本课题将进一步揭示miR-17~92家族与Notch1,c-Myc,Pten和新的分子在胸腺T细胞发育和T-ALL中的互作和上下游调控方式。上述研究有望厘清miR-17~92家族在胸腺T细胞发育和T-ALL中的作用机理,为临床治疗提供新型干预靶点。

项目摘要

胸腺T细胞发育受阻或失控能够诱发严重的免疫缺陷或T淋巴细胞白血病(T-ALL)等疾病。.厘清胸腺T细胞发育的调控机制对于揭示上述疾病的致病机理至关重要。在过去的研究中microRNA在外周T细胞的功能逐渐被揭示,但在胸腺T细胞早期发育中的作用机制仍不清楚。本课题研究发现miR-17~92家族在DN到DP过渡阶段发挥关键作用,在胸腺T细胞发育早期敲除miR-17~92家族在DP阶段严重阻断T细胞发育。我们的分子机理研究阐明了miR-17~92家族通过Pten-p21这一条分子通路调控T细胞早期发育。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Influence of Forging Temperature on the Microstructures and Mechanical Properties of a Multi-Directionally Forged Al-Cu-Li Alloy

Influence of Forging Temperature on the Microstructures and Mechanical Properties of a Multi-Directionally Forged Al-Cu-Li Alloy

DOI:10.1007/s12540-021-01022-6
发表时间:2022
2

城市生活垃圾热值的特征变量选择方法及预测建模

城市生活垃圾热值的特征变量选择方法及预测建模

DOI:10.11936/bjutxb2021010011
发表时间:2021
3

Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high risk

Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high risk

DOI:10.1080/14712598.2018.1518423
发表时间:2018
4

高盐水中硝酸根的电化学去除方法

高盐水中硝酸根的电化学去除方法

DOI:10.1360/TB-2020-0766
发表时间:2020
5

Apatinib enhanced anti-PD-1 therapy for colon cancer in mice via promoting PD-L1 expression

Apatinib enhanced anti-PD-1 therapy for colon cancer in mice via promoting PD-L1 expression

DOI:10.1016/j.intimp.2020.106858
发表时间:2020

肖昌春的其他基金

相似国自然基金

1

T 淋巴细胞的发育及胸腺基质细胞的作用

批准号:39230320
批准年份:1992
负责人:陈慰峰
学科分类:H2205
资助金额:50.00
项目类别:重点项目
2

Asb2在急性T淋巴细胞白血病中的作用及干预

批准号:81200389
批准年份:2012
负责人:吴薇
学科分类:H0809
资助金额:23.00
项目类别:青年科学基金项目
3

microRNA17~92簇在急性T淋巴细胞白血病糖皮质激素耐药中的分子机制研究

批准号:81600122
批准年份:2016
负责人:郭霞
学科分类:H0809
资助金额:14.00
项目类别:青年科学基金项目
4

骨髓脂肪细胞异常分化在急性T淋巴细胞白血病微小残留病中的作用及机制研究

批准号:81770159
批准年份:2017
负责人:纪春岩
学科分类:H0809
资助金额:58.00
项目类别:面上项目